EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Gut–Eye Axis: An Emerging Strategy to Face Ocular Diseases

Lucrezia Irene Maria Campagnoli iD, Angelica Varesi, Annalisa Barbieri iD, Nicoletta Marchesi iD, Alessia Pascale iD

International Journal of Molecular Sciences · 28.08.2023 · 24 (17) · 13338

DOI: 10.3390/ijms241713338 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.08.2023. Verfasst von Lucrezia Irene Maria Campagnoli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Sciences, Unit of Pharmacology, University of Pavia, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Glaucoma, Macular Degeneration, Diabetic Retinopathy. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human microbiota refers to a large variety of microorganisms (bacteria, viruses, and fungi) that live in different human body sites, including the gut, oral cavity, skin, and eyes. In particular, the presence of an ocular surface microbiota with a crucial role in maintaining ocular surface homeostasis by preventing colonization from pathogen species has been recently demonstrated. Moreover, recent studies underline a potential association between gut microbiota (GM) and ocular health. In this respect, some evidence supports the existence of a gut–eye axis involved in the pathogenesis of several ocular diseases, including age-related macular degeneration, uveitis, diabetic retinopathy, dry eye, and glaucoma. Therefore, understanding the link between the GM and these ocular disorders might be useful for the development of new therapeutic approaches, such as probiotics, prebiotics, symbiotics, or faecal microbiota transplantation through which the GM could be modulated, thus allowing better management of these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlaucomaMacular DegenerationDiabetic RetinopathyHumansEyeFace

Stichwörter der Autor:innen

age-related macular degenerationdiabetic retinopathydry eye diseaseglaucomagut microbiotagut–eye axisocular microbiotaprobioticssymbioticsuveitis

Autor:innen und Institutionen

  • Department of Drug Sciences, Unit of Pharmacology, University of Pavia, 27100 Pavia, Italy.
  • Department of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.

ORCID-Profile: Lucrezia Irene Maria Campagnoli, Annalisa Barbieri, Nicoletta Marchesi, Alessia Pascale

Zitieren

APA

Campagnoli, L. I. M., Varesi, A., Barbieri, A., Marchesi, N., & Pascale, A. (2023). Targeting the Gut–Eye Axis: An Emerging Strategy to Face Ocular Diseases. International Journal of Molecular Sciences, 24(17), 13338. https://doi.org/10.3390/ijms241713338

Vancouver

Campagnoli LIM, Varesi A, Barbieri A, Marchesi N, Pascale A. Targeting the Gut–Eye Axis: An Emerging Strategy to Face Ocular Diseases. International Journal of Molecular Sciences. 2023;24(17):13338. doi:10.3390/ijms241713338

BibTeX
@article{Campagnoli2023,
  author = {Campagnoli, Lucrezia Irene Maria and Varesi, Angelica and Barbieri, Annalisa and Marchesi, Nicoletta and Pascale, Alessia},
  title = {Targeting the Gut–Eye Axis: An Emerging Strategy to Face Ocular Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {17},
  pages = {13338},
  doi = {10.3390/ijms241713338}
}
Kostenlos starten →